The Growth Hormone Research Society honors one of its founders and former president, Professor Emeritus Raymond Hintz with an honorary membership.

   Ray has been instrumental in unraveling the GH-IGF axis and has been a leader in the field for 4 decades.

   He trained in the University of North Carolina during the initial days of the formation of our understanding of the biology of GH and has been the co-discoverer of the IGF-binding proteins. Soon afterwards, he settled in Stanford University where he created a leading research and training program in the field.

   His career spanned the spectrum of basic research, clinical research, teaching and patient care. He trained dozens of fellows, received scores of grants, was bestowed many honors and awards, and authored hundreds of papers.

   His lab developed important novel assays for GH-IGF axis components including, for example, the first ALS assay.

   Arguably, Ray's greatest contribution to the field has been his leadership in advancing GH therapy to new indications beyond GHD, most notably, ISS, with his classic paper in NEJM, paving the way to the approval of GH for this condition.

   Dr. Hintz retired from Stanford University in 2006 and lives in Palo Alto with his wife Carol. He continues to attend academic meetings. His work continues to influence and inspire all of us in the field.